← Back to Screener
iSpecimen Inc. Common Stock (ISPC)
Price$0.12
Favorite Metrics
Price vs S&P 500 (26W)-92.76%
Price vs S&P 500 (4W)-49.92%
Market Capitalization$3.32M
All Metrics
Book Value / Share (Quarterly)$0.36
P/TBV (Annual)3.11x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-42.97%
Cash Flow / Share (Quarterly)$-0.62
Price vs S&P 500 (YTD)-59.66%
Gross Margin (TTM)1.25%
Net Profit Margin (TTM)-543.68%
EPS (TTM)$-2.26
10-Day Avg Trading Volume53.89M
EPS Excl Extra (TTM)$-2.26
Revenue Growth (5Y)-25.09%
EPS (Annual)$-2.28
ROI (Annual)-339.60%
Gross Margin (Annual)1.25%
Net Profit Margin (5Y Avg)-193.80%
Cash / Share (Quarterly)$0.81
Revenue Growth QoQ (YoY)-96.49%
ROA (Last FY)-110.03%
Revenue Growth TTM (YoY)-79.24%
EBITD / Share (TTM)$-2.27
ROE (5Y Avg)-182.31%
Operating Margin (TTM)-465.42%
Cash Flow / Share (Annual)$-0.62
P/B Ratio1.07x
P/B Ratio (Quarterly)0.82x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)-1.85x
Net Interest Coverage (TTM)-95.40x
ROA (TTM)-133.57%
EPS Incl Extra (Annual)$-2.28
Current Ratio (Annual)1.12x
Quick Ratio (Quarterly)1.11x
3-Month Avg Trading Volume11.72M
52-Week Price Return-91.20%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.10
P/S Ratio (Annual)1.72x
Asset Turnover (Annual)0.20x
52-Week High$3.18
Operating Margin (5Y Avg)-177.19%
EPS Excl Extra (Annual)$-2.28
CapEx CAGR (5Y)-1.88%
26-Week Price Return-88.77%
Quick Ratio (Annual)1.11x
13-Week Price Return-63.88%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.12x
Enterprise Value$-3.565
Revenue / Share Growth (5Y)-19.77%
Asset Turnover (TTM)0.25x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-543.68%
Cash / Share (Annual)$0.81
3-Month Return Std Dev146.82%
Gross Margin (5Y Avg)40.56%
Net Income / Employee (TTM)$-0
ROE (Last FY)-339.60%
Net Interest Coverage (Annual)-45.69x
EPS Basic Excl Extra (Annual)$-2.28
Receivables Turnover (TTM)2.58x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.26
Receivables Turnover (Annual)2.58x
ROI (TTM)-496.37%
P/S Ratio (TTM)1.72x
Pretax Margin (5Y Avg)-193.80%
Revenue / Share (Annual)$0.42
Tangible BV / Share (Annual)$0.10
Price vs S&P 500 (52W)-121.03%
Year-to-Date Return-57.02%
5-Day Price Return-14.07%
EPS Normalized (Annual)$-2.28
ROA (5Y Avg)-76.11%
Net Profit Margin (Annual)-543.68%
Month-to-Date Return-28.79%
Cash Flow / Share (TTM)$-0.92
EBITD / Share (Annual)$-2.26
Operating Margin (Annual)-465.42%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-181.69%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-2.26
P/TBV (Quarterly)3.11x
P/B Ratio (Annual)0.82x
Pretax Margin (TTM)-543.68%
Book Value / Share (Annual)$0.36
Price vs S&P 500 (13W)-64.56%
Beta1.82x
Revenue / Share (TTM)$0.25
ROE (TTM)-496.37%
52-Week Low$0.10
Analyst Recommendations
Sep 2024
Oct 2024
Nov 2024
Dec 2024
4.14
4.14
4.14
4.14
Industry Peers — R&D — Physical Sciences(9)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|
ISPCiSpecimen Inc. Common Stock | — | -496.37% | -25.09% | — | $0.12 |
IQVIQVIA Holdings Inc. | 22.22x | 22.28% | 7.50% | — | $171.95 |
INCYIncyte Genomics Inc | 14.67x | 29.15% | 14.03% | — | $95.32 |
MEDPMedpace Holdings, Inc. Common Stock | 32.83x | 118.82% | 22.27% | — | $515.65 |
CRLCharles River Laboratories International, Inc. | — | -4.40% | 6.55% | — | $176.94 |
ABSIAbsci Corporation Common Stock | — | -59.68% | -10.14% | — | $3.23 |
NRCNational Research Corporation Common Stock (Delaware) | 34.98x | 58.51% | 0.61% | 3.59% | $17.62 |
OABIOmniAb, Inc. Common Stock | — | -23.99% | -4.31% | — | $1.56 |
MXCTMaxCyte, Inc. Common Stock | — | -24.06% | 4.76% | — | $0.82 |
NOTVInotiv, Inc. Common Stock | — | -50.77% | 53.35% | — | $0.30 |
About
iSpecimen Inc is a technology-enabled biospecimen supplier that connects life science researchers and pharmaceutical companies with human tissues, fluids, and stem cells. The company procures specimens from hospitals, laboratories, and medical facilities globally, with operations primarily concentrated in the Americas. iSpecimen enables drug development and clinical research by providing researchers access to the biosamples necessary for their studies.